Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10026838HBVENSG00000139131.13protein_codingYARS2NoNo51067Q9Y2Z4
TVIS30032472HIVENSG00000139131.13protein_codingYARS2NoNo51067Q9Y2Z4
TVIS20066795HPVENSG00000139131.13protein_codingYARS2NoNo51067Q9Y2Z4
TCGA Plot Options
Drug Information
GeneYARS2
DrugBank IDDB00135
Drug NameTyrosine
Target IDBE0000363
UniProt IDQ9Y2Z4
Regulation Type
PubMed IDs17139284; 17016423; 15840835; 12097643; 12754495
CitationsOverington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.@@Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.@@Zhang Y, Wang L, Schultz PG, Wilson IA: Crystal structures of apo wild-type M. jannaschii tyrosyl-tRNA synthetase (TyrRS) and an engineered TyrRS specific for O-methyl-L-tyrosine. Protein Sci. 2005 May;14(5):1340-9.@@Kiga D, Sakamoto K, Kodama K, Kigawa T, Matsuda T, Yabuki T, Shirouzu M, Harada Y, Nakayama H, Takio K, Hasegawa Y, Endo Y, Hirao I, Yokoyama S: An engineered Escherichia coli tyrosyl-tRNA synthetase for site-specific incorporation of an unnatural amino acid into proteins in eukaryotic translation and its application in a wheat germ cell-free system. Proc Natl Acad Sci U S A. 2002 Jul 23;99(15):9715-20. Epub 2002 Jul 3.@@Kobayashi T, Nureki O, Ishitani R, Yaremchuk A, Tukalo M, Cusack S, Sakamoto K, Yokoyama S: Structural basis for orthogonal tRNA specificities of tyrosyl-tRNA synthetases for genetic code expansion. Nat Struct Biol. 2003 Jun;10(6):425-32.
GroupsApproved; Investigational; Nutraceutical
Direct ClassificationTyrosine and derivatives
SMILESN[C@@H](CC1=CC=C(O)C=C1)C(O)=O
PathwaysDopamine beta-Hydroxylase Deficiency; Tyrosine Metabolism; Thyroid Hormone Synthesis; Disulfiram Action Pathway; Aromatic L-Aminoacid Decarboxylase Deficiency; Monoamine Oxidase-A Deficiency (MAO-A); Catecholamine Biosynthesis; Phenylketonuria; Tyrosinemia, Transient, of the Newborn; Tyrosinemia Type 3 (TYRO3); Hawkinsinuria; Tyrosinemia Type 2 (or Richner-Hanhart Syndrome); Phenylalanine and Tyrosine Metabolism; Tyrosinemia Type I; Alkaptonuria; Tyrosine Hydroxylase Deficiency
PharmGKBPA451822
ChEMBLCHEMBL925